Treatment of pubalgia by mesotherapy, study of 51 cases

Miljkovic, Darko; Demarais, Y.; Laurens, Denis

doi:10.1016/j.rehab.2013.07.1055

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mesotherapy is an array of microinjection techniques primarily used for body contouring and reduction of subcutaneous fat [2][3][4][5] ; this was first described by Michel Pistor in 1952. 6 Other applications for treatment with mesotherapy are being investigated, including for skin rejuvenation, 7,8 nasal pore closure, 9 alopecia, 10 lipomatosis, 11 musculoskeletal and neuromuscular pain relief, [12][13][14][15][16][17] carpal tunnel syndrome, 18 venous insufficiency, 19 and frostbite. 20 Unlike FDA-approved injection of deoxycholic acid for non-surgical fat reduction, 21 mesotherapy is largely unregulated and may contain various compounds which have not been standardized.…”

Section: Introductionmentioning

confidence: 99%

Clinical features of mesotherapy-associated non-tuberculous mycobacterial infections: A systematic review

Singsing,

Duncan,

Vachon

et al. 2022

International Journal of Women’s Dermatology

View full text Add to dashboard Cite

Background: Cutaneous infections from non-tuberculous mycobacteria (NTM) are a well-documented but poorly characterized adverse event following mesotherapy injections. Objective: This study aims to consolidate the available literature to characterize demographic and clinical features of mesotherapy-associated NTM infections. Methods: Using PRISMA guidelines, a systematic review of PubMed, Scopus, and Embase databases was undertaken for articles reporting cases of NTM skin infections following mesotherapy. Data were analyzed using Microsoft Excel. Results: Of 1966 search results, 30 articles (N = 423 patients) met inclusion criteria. Studies were largely from South America, and patients were mostly women aged 16-55 with NTM infections arising in the abdomen, buttocks, or thighs. Nearly all patients developed multiple, well-localized lesions without systemic symptoms. Effect summary by meta-analysis revealed most infections resolved after antibiotic therapy, though many patients required multiple antibiotic courses and/or agents to resolve infection. Infections often took weeks to resolve and were complicated by post-treatment scarring. Limitations: The main limitation of this study was the heterogeneity and lack of consistency between case reports. Conclusion: Cutaneous NTM infections associated with mesotherapy generally occur in women of childbearing age, arise from injections contaminated by the environment, and are often complicated by scarring/poor cosmesis and prolonged treatment course.

show abstract